scholarly article | Q13442814 |
P819 | ADS bibcode | 2012PLoSO...742279Q |
P356 | DOI | 10.1371/JOURNAL.PONE.0042279 |
P932 | PMC publication ID | 3409178 |
P698 | PubMed publication ID | 22860105 |
P5875 | ResearchGate publication ID | 230616984 |
P2093 | author name string | Floyd E Romesberg | |
Cristina Gil-Lamaignere | |||
Félix Machín | |||
Ana Canerina-Amaro | |||
David Quinto-Alemany | |||
Luís G Hernández-Abad | |||
P2860 | cites work | Flucytosine monotherapy for cryptococcosis. | Q54127839 |
Growth response of several Candida albicans strains to inhibitory concentrations of heavy metals | Q67814972 | ||
Mutations of Bacteria from Virus Sensitivity to Virus Resistance | Q24533278 | ||
SMC5 and SMC6 genes are required for the segregation of repetitive chromosome regions. | Q27930040 | ||
Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions | Q28143025 | ||
Mechanisms of action of 5-fluorocytosine | Q28366384 | ||
The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans | Q28469346 | ||
DNA recombination: the replication connection. | Q33677006 | ||
An examination of adaptive reversion in Saccharomyces cerevisiae | Q33959891 | ||
The paradox of response and survival in cancer therapeutics | Q34449433 | ||
Transient and heritable mutators in adaptive evolution in the lab and in nature | Q34603730 | ||
Adaptive mutation in Saccharomyces cerevisiae | Q34661313 | ||
Mutation as a stress response and the regulation of evolvability | Q35869358 | ||
Yeast on drugs: Saccharomyces cerevisiae as a tool for anticancer drug research. | Q36803222 | ||
Stress-induced mutagenesis in bacteria. | Q36961683 | ||
Selection-induced mutations occur in yeast | Q37001654 | ||
Treatment-dependent androgen receptor mutations in prostate cancer exploit multiple mechanisms to evade therapy | Q37396357 | ||
MAPK cell-cycle regulation in Saccharomyces cerevisiae and Candida albicans | Q37772895 | ||
Hypoxia imaging predicts success of hypoxia-induced cytosine deaminase/5-fluorocytosine gene therapy in a murine lung tumor model | Q39405515 | ||
Antifungal resistance and new strategies to control fungal infections | Q39751373 | ||
Non-homologous end joining as an important mutagenic process in cell cycle-arrested cells | Q39756406 | ||
Possible role of adaptive mutation in resistance to antiandrogen in prostate cancer cells | Q40397912 | ||
beta-lactam antibiotics induce the SOS response and horizontal transfer of virulence factors in Staphylococcus aureus | Q43259790 | ||
The role of the SOS response in bacteria exposed to zidovudine or trimethoprim | Q44084572 | ||
SOS response induction by beta-lactams and bacterial defense against antibiotic lethality | Q45016731 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e42279 | |
P577 | publication date | 2012-01-01 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Yeasts acquire resistance secondary to antifungal drug treatment by adaptive mutagenesis | |
P478 | volume | 7 |